Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02569476
What this trial is testing

BGB 3111 in Combination With Obinutuzumab in Participants With B-Cell Lymphoid Malignancies

Who this might be right for
B-cell Lymphoid Malignancies
BeiGene 119
Testing effectiveness (Phase 2)Study completedNCT00005041
What this trial is testing

R115777 in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Lung Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT03799731
What this trial is testing

Study for Evaluation of Murlentamab (GM102) Anti-tumoral Activity in Colorectal Cancers

Who this might be right for
Colorectal Cancer
GamaMabs Pharma 65
Early research (Phase 1)Study completedNCT06235983
What this trial is testing

LY3537982 in Chinese Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Eli Lilly and Company 12
Testing effectiveness (Phase 2)Looking for participantsNCT06427941
What this trial is testing

BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more
BeOne Medicines 630
Testing effectiveness (Phase 2)Ended earlyNCT03379259
What this trial is testing

Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
BeiGene 39
Early research (Phase 1)Study completedNCT00816361
What this trial is testing

A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors

Who this might be right for
Cancer
MedImmune LLC 43
Early research (Phase 1)Looking for participantsNCT06120283
What this trial is testing

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced Breast CancerMetastatic Breast Cancer+5 more
BeOne Medicines 433
Large-scale testing (Phase 3)Looking for participantsNCT06624644
What this trial is testing

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Who this might be right for
Melanoma (Skin Cancer)Melanoma Stage IIIB-IVCutaneous Melanoma+1 more
Linnaeus Therapeutics, Inc. 135
Not applicableStudy completedNCT02022098
What this trial is testing

Debio 1143-201 Dose-finding and Efficacy Phase I/II Trial

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Debiopharm International SA 144
Early research (Phase 1)Study completedNCT00816400
What this trial is testing

A Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors.

Who this might be right for
Cancer
MedImmune LLC 49
Testing effectiveness (Phase 2)Study completedNCT05993299
What this trial is testing

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Who this might be right for
Neoplasms
USWM, LLC (dba US WorldMeds) 7
Early research (Phase 1)Ended earlyNCT05381909
What this trial is testing

BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

Who this might be right for
Solid Tumor, Adult
BeiGene 157
Testing effectiveness (Phase 2)Active Not RecruitingNCT05632939
What this trial is testing

ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer.

Who this might be right for
Gastric CancerGastroesophageal Cancer (GC)
AskGene Pharma, Inc. 62
Early research (Phase 1)Ended earlyNCT03218683
What this trial is testing

Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia (AML)
AstraZeneca 70
Early research (Phase 1)Ended earlyNCT05494762
What this trial is testing

Safety, Pharmacokinetics, and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab (BGB-A317) in Participants With Advanced Solid Tumors

Who this might be right for
Solid Tumor
BeiGene 55
Early research (Phase 1)Active Not RecruitingNCT03530397
What this trial is testing

Evaluate MEDI5752 in Subjects With Advanced Solid Tumors

Who this might be right for
Selected Advanced Solid Tumors
MedImmune LLC 400
Testing effectiveness (Phase 2)Looking for participantsNCT05867251
What this trial is testing

Study of AVZO-021 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorHR+/HER2- Breast CancerHR+, HER2-, Advanced Breast Cancer+6 more
Avenzo Therapeutics, Inc. 430
Testing effectiveness (Phase 2)Looking for participantsNCT05288205
What this trial is testing

Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation

Who this might be right for
KRAS P.G12CNon-small Cell Lung CancerColorectal Cancer+1 more
Allist Pharmaceuticals, Inc. 240
Early research (Phase 1)Study completedNCT01526473
What this trial is testing

A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901

Who this might be right for
HER2+ Cancer
H. Kim Lyerly 22
Next Page